Diffuse idiopathic skeletal hyperostosis (Forestier-Rotes-Querol disease): What's new?

Joint Bone Spine

Volumn 80, Issue 5, 2013, Pages 466-470

  Mazières, Bernard ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Diffuse idiopathic skeletal hyperostosis; DKK 1; Enthesophyte; Forestier disease; Vertebral fractures; Vertebral hyperostosis

Indexed keywords

DICKKOPF 1 PROTEIN;

ANKYLOSING HYPEROSTOSIS; CERVICAL SPINE FRACTURE; COMORBIDITY; DISEASE SEVERITY; DYSPHAGIA; ESOPHAGUS STENOSIS; HUMAN; HYPEROSTOSIS; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; OBESITY; OSSIFICATION; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RISK FACTOR; SHORT SURVEY; SPONDYLARTHRITIS; SYMPTOMATOLOGY;

DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS; DKK-1; ENTHESOPHYTE; FORESTIER DISEASE; VERTEBRAL FRACTURES; VERTEBRAL HYPEROSTOSIS;

COMORBIDITY; HUMANS; HYPEROSTOSIS, DIFFUSE IDIOPATHIC SKELETAL; RISK FACTORS;

EID: 84885925227     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2013.02.011     Document Type: Short Survey

References (39)

1. Forestier J., Rotès-Quérol J. Hyperostosis of the spine. Ann Rheum Dis 1950, 9:321-330.
2. Resnick D., Shaul R.S., Robins J.M. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier's disease with extraspinal manifestations. Radiology 1975, 115:513-524.
3. Verdone F. Diffuse idiopathic skeletal hyperostosis in the third millennium: is there (yet) cause for concern (letter)?. J Rheumatol 2010, 37:1356-1357.
4. Ullrich H. Goethe's skull and skeleton. Anthropol Anz 2002, 60:341-368.
5. Chhem R.K., Schmit P., Fauré C. Did Ramesses II really have ankylosing spondylitis? A reappraisal. Can Axxoc Radiol J 2004, 55:211-217.
6. Weisz G.M., Matucci-Cerinic M., Lippi D., et al. The ossification diathesis in the Medici family: DISH and other features. Rheumatol Int 2011, 31:1649-1652.
7. Utsinger P.D. Diffuse idiopathic skeletal hyperostosis (DISH, ankylosing hyperostosis). Osteoarthritis. Diagnostic and management 1984, 225-233. WB Saunders, Philadelphia. R.W. Moskowitz, D.S. Howell, V.M. Goldberg, H.J. Mankin (Eds.).
8. Mader R. Diffuse idiopathic skeletal hyperostosis: time for a change. J Rheumatol 2008, 35:377-379.
9. Van der Merwe A.E., Maat G.J., Watt I. Diffuse idiopathic skeletal hyperostosis: diagnosis in a palaeopathological context. Homo 2012, 63:202-215.
10. Holton K.F., Denard P.J., Yoo J.U., et al. Diffuse idiopathic skeletal hyperostosis and its relation to back pain among older men: the MrOS study. Semin Arthritis Rheum 2011, 41:131-138.
11. Baraliakos X., Listing J., Buschmann J., et al. A comparing of new bone formation in ankylosing spondylitis and patients with diffuse idiopathic skeletal hyperostosis: a retrospective cohort study over 6 years. Arthritis Rheum 2011, 64:1127-1133.
12. Dar G., Peleg S., Masharawi Y., et al. The association of sacroiliac joint bridging with other enthesopathies in the human body. Spine 2007, 32:E303-E308.
13. Mader R., Buskila D., Verlaan J.J., et al. Developing new classification criteria for diffuse idiopathic skeletal hyperostosis: back to square one. Rheumatology (Oxford) 2013, 52:326-330.
14. Verlaan J.J., Boswijk P.F., de Ru J.A., et al. Diffuse idiopathic skeletal hyperostosis of the cervical spine: an underestimated cause of dysphagia and airway obstruction. Spine J 2012, 11:1058-1067.
15. Clark E., Preston P., Wates A., et al. DISHphagia-a difficult problem to swallow (letter). Rheumatology 2003, 42:1422-1423.
16. Winslow C.P., Winslow T.J., Wax M.K. Dysphonia and dysphagia following the anterior approach to the cervical spine. Arch Otolaryngol 2001, 27:51-55.
17. Urrutia J., Bono C.M. Long-term results of surgical treatment of dysphagia secondary to cervical diffuse idiopathic skeletal hyperostosis. Case report. Spine J 2009, 9:E13-E17.
18. Rathinam S., Makarawo T., Norton R., et al. Thoracic osteophyte: rare cause of esophageal perforation. Dis Esophagus 2010, 23:E5-E8.
19. Ngian G.S., Littlejohn G.O. Is DISH painful?. J Rheumatol 2010, 37:1797-1799.
20. Mader R., Novofastovski I., Rosner E., et al. Nonarticular tenderness and functional status in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 2010, 37:1911-1916.
21. Westerveld L.A., Verlaan J.J., Oner F.C. Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications. Eur Spine J 2009, 18:145-156.
22. Verlaan J.J., Westerveld L.A., van Keulen J.W., et al. Quantitative analysis of the anterolateral ossification mass in diffuse idiopathic skeletal hyperostosis of the thoracic spine. Eur Spine J 2011, 20:1474-1479.
23. Caron T., Bransford R., Nguyen Q., et al. Spine fractures in patients with ankylosing spinal disorders. Spine 2010, 35:E458-E464.
24. Schoenfeld A.J., Harris M.B., McGuire K.J., et al. Mortality in elderly patients with hyperostotic disease of the cervical spine after fracture: an age- and sex-matched study. Spine J 2011, 11:257-264.
25. Mader R., Sarzi-Puttini P., Atzeni F., et al. Extraspinal manifestations of diffuse idiopathic skeletal hyperostosis. Rheumatology (Oxford) 2009, 48:1478-1481.
26. Senolt L., Hulejova H., Krystufkova O., et al. Low circulating Dickkopf-1 and its link with severity of spinal involvement in diffuse idiopathic skeletal hyperostosis. ARD 2012, 71:71-74.
27. Aeberti D., Schett G., Eser P., et al. Serum Dkk-1 levels of DISH patients are not different from healthy controls (letter). Joint Bone Spine 2011, 78:422-423.
28. Abiteboul M., Arlet J., Sarrabay M.A., et al. Métabolisme de la vitamine A dans l'hyperostose de Forestier et Rotès-Quérol. Rev Rhum 1986, 53:143-145. [In French].
29. Seawright A.A., English P.B., Gartner R.J. Hypervitaminosis A and hyperostosis of the cat. Nature 1965, 206:1171-1172.
30. Pittsley R.A., Yoder F.W. Retinoid hyperostosis skeletal toxicity associated with long-term administration of 13-cis-retinoic acid for refractory ichthyosis. N Engl J Med 1983, 308:1012-1014.
31. Nesher G., Zuckner J. Rheumatologic complications of vitamin A and retinoids. Semin Arthritis Rheum 1995, 24:291-296.
32. Schadt C.R., Zic J.A., Fuchs H.A. Diffuse idiopathic skeletal hyperostosis associated with bexarotene (letter). J Am Acad Dermatol 2011, 65:883-884.
33. Saetia K., Cho D., Lee S., et al. Ossification of the posterior longitudinal ligament: a review. Neurosurg Focus 2011, 30:E1-E16.
34. Jun J.K., Kim S.M. Association study of fibroblast growth factor 2 and fibroblast growth factor receptors gene polymorphism in Korean ossification of the posterior longitudinal ligament patients. J Korean Neurosurg Soc 2012, 52:7-13.
35. Tsukahara S., Miyazawa N., Akagawa H., et al. COL6A1, the candidate gene for ossification of the posterior longitudinal ligament, is associated with diffuse idiopathic skeletal hyperostosis in Japanese. Spine 2005, 30:2321-2324.
36. Jiang Y., Hu H., Ye X., et al. Multilevel myelopathy associated with pseudohypoparathyroidism simulating diffuse skeletal hyperostosis. A case report and literature review. Spine 2010, 35:E1355-E1358.
37. Kiss C., Szilàgyi M., Paksy A., et al. Risk factors for diffuse idiopathic skeletal hyperostosis: a case-control study. Rheumatology (Oxford) 2002, 41:27-30.
38. Zincarelli C., Iervolino S., Di Minno M.N., et al. Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Arthritis Care Res (Hoboken) 2012, 64:1765-1769.
39. Mader R., Novofestovski I., Adawi M., et al. Metabolic syndrome and cardiovascular risk in patients with diffuse idiopathic skeletal hyperostosis. Semin Arthritis Rheum 2009, 38:361-365.